Adma Biologics (ADMA) Preferred Shares (2011)

Adma Biologics (ADMA) reported Preferred Shares of $8222.0 for Q4 2011.

Adma Biologics (ADMA) Preferred Shares (2011) Analysis & Trends

Adma Biologics has reported Preferred Shares for 1 years, with the latest figure at $8222.0 in Q4 2011.

For the quarter ending Q4 2011, Preferred Shares changed N/A year-over-year to $8222.0; the trailing twelve-month figure through Dec 2011 stood at $8222.0 (changed N/A YoY), and the FY2011 full-year result was $8222.0, changed N/A from the prior year.
Preferred Shares for Q4 2011 stood at $8222.0.
The five-year high for Preferred Shares was $8222.0 in Q4 2011, with the low at $8222.0 in Q4 2011.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Adma Biologics	1.98 Bn	1.89 Bn	88.82 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2011	8,222.00